InvestorsHub Logo
Followers 6
Posts 607
Boards Moderated 0
Alias Born 02/25/2017

Re: None

Sunday, 04/02/2017 4:32:36 PM

Sunday, April 02, 2017 4:32:36 PM

Post# of 195
Boston Scientific Announces Agreement to Acquire Symetis

The Symetis portfolio includes the ACURATE TA™ and ACURATE neo/TF valve* systems for use in the treatment of high-risk patients suffering from severe and symptomatic aortic valve stenosis, which are sold in Europe and in other geographies outside of the United States. Symetis is also developing the ACURATE neo/AS** next generation valve system, currently in a clinical trial intended to serve as the basis for a future CE mark application.



http://www.prnewswire.com/news-releases/boston-scientific-announces-agreement-to-acquire-symetis-300431660.html

252023202112011074207

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BSX News